Patents by Inventor Anupam Agarwal

Anupam Agarwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11945781
    Abstract: The present disclosure is concerned with thioquinolinone compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: March 14, 2023
    Date of Patent: April 2, 2024
    Assignees: Southern Research Institute, UAB Research Foundation, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor
  • Publication number: 20230339860
    Abstract: The present disclosure is concerned with thioquinolinone compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: March 14, 2023
    Publication date: October 26, 2023
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor
  • Patent number: 11753374
    Abstract: The present disclosure is concerned with biaryl aminomaleimide compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: September 12, 2023
    Assignees: Southern Reserach Institute, The UAB Research Foundation, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor
  • Publication number: 20230219958
    Abstract: The present disclosure is concerned with purine diamine compounds for the treatment of conditions associated with BRD4, RIP3K, and/or IL6 signaling dysfunction such as, for example, cancer (e.g., lung cancer, skin cancer, bladder cancer, kidney cancer, liver cancer), arsenicosis, arsenic poisoning, inflammation, skin lesions, dysfunction of systemic organs, and skin blisters. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: January 10, 2023
    Publication date: July 13, 2023
    Inventors: Mark J. Suto, Bini Mathew, Corinne E. Augelli-Szafran, Marina Fosso Yatchang, Mohammad Athar, Anupam Agarwal, Ritesh Kumar Srivastava, Suhail Muzaffar, Jasim Khan
  • Patent number: 11623918
    Abstract: The present disclosure is concerned with thioquinolinone compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: April 11, 2023
    Assignees: Southern Research Institute, UAB Research Foundation, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor
  • Publication number: 20220153702
    Abstract: The present disclosure is concerned with thioquinolinone compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 17, 2021
    Publication date: May 19, 2022
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor
  • Publication number: 20220153695
    Abstract: The present disclosure is concerned with biaryl aminomaleimide compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: November 17, 2021
    Publication date: May 19, 2022
    Inventors: Mark J. Suto, Bini Mathew, Anupam Agarwal, Amie M. Traylor